We now offer access to the GARD® technology platform, a second generation of in vitro assays for skin sensitization testing based on genomics and machine learning. The GARD® technology platform, developed by SenzaGen AB, is intended to gradually replace all...
Complying with EU Medical Device Regulation (MDR) is not optional. If you are a manufacturer, authorised representative or distributor of medical devices, you will need to ensure compliance with EU MDR. Non-compliance with biological safety requirements can result in...
As a member of the DTU family, we would like to congratulate the 19 participants in the 2022 Danish Tech Challenge, Denmark’s leading accelerator for hardware start-ups, at the DTU Science Park Futurebox incubator. At SAXOCON, we specialise in in-silico...
Exposure to aerosols can negatively affect health. Using our SAXOCON Impactor tool, we can determine what is in the air at your workplace, if there are any risks, and how to mitigate potential problems. We designed and built the SAXOCON Impactor to be a highly...
Our CSO, Kirsten Inga Kling, has joined GAeF (Gesellschaft für Aerosolforschung e.V.) as a supporting member. We look forward to contributing to the discussion, learning, and sharing knowledge with other experts in aerosol research. Check out our analytics services...
SAXOCON congratulates Arla Foods Ingredients on the positive EFSA opinion regarding their novel food application for Lacroprodan® BLG-100. We are proud that our contribution helped get the application over the finish line and look forward to Arla receiving full EU...
